Go Pro

TwentyFour Select Monthly Income Fund (SMIF) Competitors

TwentyFour Select Monthly Income Fund logo
GBX 85.70 +0.30 (+0.35%)
As of 12:43 PM Eastern

SMIF vs. JFJ, GROW, FCSS, BPCR, and EDIN

Should you buy TwentyFour Select Monthly Income Fund stock or one of its competitors? TwentyFour Select Monthly Income Fund's main competitors and comparable companies include JPMorgan Japanese (JFJ), Molten Ventures (GROW), Fidelity China Special (FCSS), BioPharma Credit (BPCR), and Edinburgh Investment (EDIN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does TwentyFour Select Monthly Income Fund compare to JPMorgan Japanese?

JPMorgan Japanese (LON:JFJ) and TwentyFour Select Monthly Income Fund (LON:SMIF) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, media sentiment and dividends.

JPMorgan Japanese pays an annual dividend of GBX 8.70 per share and has a dividend yield of 1.1%. TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.2%. JPMorgan Japanese pays out 5.8% of its earnings in the form of a dividend. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

JPMorgan Japanese has higher revenue and earnings than TwentyFour Select Monthly Income Fund. JPMorgan Japanese is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JPMorgan Japanese£245.55M4.97£194.81M£149.065.46
TwentyFour Select Monthly Income Fund£17.70M18.10N/A£5.7514.90

18.9% of JPMorgan Japanese shares are owned by institutional investors. Comparatively, 15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. 0.1% of JPMorgan Japanese shares are owned by insiders. Comparatively, 0.1% of TwentyFour Select Monthly Income Fund shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, JPMorgan Japanese's average media sentiment score of 0.00 equaled TwentyFour Select Monthly Income Fund'saverage media sentiment score.

Company Overall Sentiment
JPMorgan Japanese Neutral
TwentyFour Select Monthly Income Fund Neutral

JPMorgan Japanese has a net margin of 96.52% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. JPMorgan Japanese's return on equity of 20.00% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
JPMorgan Japanese96.52% 20.00% 8.06%
TwentyFour Select Monthly Income Fund 57.51%5.95%N/A

JPMorgan Japanese has a beta of 1.026, indicating that its share price is 3% more volatile than the broader market. Comparatively, TwentyFour Select Monthly Income Fund has a beta of 0.657, indicating that its share price is 34% less volatile than the broader market.

Summary

JPMorgan Japanese beats TwentyFour Select Monthly Income Fund on 8 of the 12 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to Molten Ventures?

Molten Ventures (LON:GROW) and TwentyFour Select Monthly Income Fund (LON:SMIF) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment.

40.5% of Molten Ventures shares are owned by institutional investors. Comparatively, 15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. 1.6% of Molten Ventures shares are owned by insiders. Comparatively, 0.1% of TwentyFour Select Monthly Income Fund shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Molten Ventures has a beta of 1.9564402, indicating that its stock price is 96% more volatile than the broader market. Comparatively, TwentyFour Select Monthly Income Fund has a beta of 0.657, indicating that its stock price is 34% less volatile than the broader market.

In the previous week, Molten Ventures had 3 more articles in the media than TwentyFour Select Monthly Income Fund. MarketBeat recorded 3 mentions for Molten Ventures and 0 mentions for TwentyFour Select Monthly Income Fund. Molten Ventures' average media sentiment score of 0.29 beat TwentyFour Select Monthly Income Fund's score of 0.00 indicating that Molten Ventures is being referred to more favorably in the media.

Company Overall Sentiment
Molten Ventures Neutral
TwentyFour Select Monthly Income Fund Neutral

Molten Ventures has a net margin of 75.09% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. Molten Ventures' return on equity of 9.21% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Molten Ventures75.09% 9.21% -3.46%
TwentyFour Select Monthly Income Fund 57.51%5.95%N/A

TwentyFour Select Monthly Income Fund has lower revenue, but higher earnings than Molten Ventures. Molten Ventures is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Molten Ventures£148M8.00-£33.58M£69.009.93
TwentyFour Select Monthly Income Fund£17.70M18.10N/A£5.7514.90

Molten Ventures currently has a consensus target price of GBX 638.67, indicating a potential downside of 6.83%. Given Molten Ventures' stronger consensus rating and higher possible upside, analysts plainly believe Molten Ventures is more favorable than TwentyFour Select Monthly Income Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Molten Ventures
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
TwentyFour Select Monthly Income Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Molten Ventures beats TwentyFour Select Monthly Income Fund on 12 of the 15 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to Fidelity China Special?

Fidelity China Special (LON:FCSS) and TwentyFour Select Monthly Income Fund (LON:SMIF) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and institutional ownership.

Fidelity China Special has higher revenue and earnings than TwentyFour Select Monthly Income Fund. Fidelity China Special is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fidelity China Special£146.54M7.85£997.06M£29.758.50
TwentyFour Select Monthly Income Fund£17.70M18.10N/A£5.7514.90

Fidelity China Special pays an annual dividend of GBX 8 per share and has a dividend yield of 3.2%. TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.2%. Fidelity China Special pays out 26.9% of its earnings in the form of a dividend. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, Fidelity China Special's average media sentiment score of 0.00 equaled TwentyFour Select Monthly Income Fund'saverage media sentiment score.

Company Overall Sentiment
Fidelity China Special Neutral
TwentyFour Select Monthly Income Fund Neutral

Fidelity China Special has a net margin of 81.41% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. Fidelity China Special's return on equity of 9.12% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Fidelity China Special81.41% 9.12% N/A
TwentyFour Select Monthly Income Fund 57.51%5.95%N/A

7.8% of Fidelity China Special shares are owned by institutional investors. Comparatively, 15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. 0.1% of Fidelity China Special shares are owned by insiders. Comparatively, 0.1% of TwentyFour Select Monthly Income Fund shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Fidelity China Special has a beta of 0.919, indicating that its stock price is 8% less volatile than the broader market. Comparatively, TwentyFour Select Monthly Income Fund has a beta of 0.657, indicating that its stock price is 34% less volatile than the broader market.

Summary

Fidelity China Special beats TwentyFour Select Monthly Income Fund on 6 of the 11 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to BioPharma Credit?

BioPharma Credit (LON:BPCR) and TwentyFour Select Monthly Income Fund (LON:SMIF) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 726.1%. TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.2%. BioPharma Credit pays out 61.4% of its earnings in the form of a dividend. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. BioPharma Credit is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, BioPharma Credit had 1 more articles in the media than TwentyFour Select Monthly Income Fund. MarketBeat recorded 1 mentions for BioPharma Credit and 0 mentions for TwentyFour Select Monthly Income Fund. BioPharma Credit's average media sentiment score of 0.84 beat TwentyFour Select Monthly Income Fund's score of 0.00 indicating that BioPharma Credit is being referred to more favorably in the media.

Company Overall Sentiment
BioPharma Credit Positive
TwentyFour Select Monthly Income Fund Neutral

BioPharma Credit has a beta of 0.22688746, suggesting that its stock price is 77% less volatile than the broader market. Comparatively, TwentyFour Select Monthly Income Fund has a beta of 0.657, suggesting that its stock price is 34% less volatile than the broader market.

31.3% of BioPharma Credit shares are owned by institutional investors. Comparatively, 15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. 0.1% of BioPharma Credit shares are owned by insiders. Comparatively, 0.1% of TwentyFour Select Monthly Income Fund shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

BioPharma Credit has higher revenue and earnings than TwentyFour Select Monthly Income Fund. BioPharma Credit is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioPharma Credit£132.06M0.08£10.42B£11.400.08
TwentyFour Select Monthly Income Fund£17.70M18.10N/A£5.7514.90

BioPharma Credit has a net margin of 92.62% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. BioPharma Credit's return on equity of 11.29% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
BioPharma Credit92.62% 11.29% 4.98%
TwentyFour Select Monthly Income Fund 57.51%5.95%N/A

Summary

BioPharma Credit beats TwentyFour Select Monthly Income Fund on 10 of the 14 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to Edinburgh Investment?

TwentyFour Select Monthly Income Fund (LON:SMIF) and Edinburgh Investment (LON:EDIN) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

Edinburgh Investment has higher revenue and earnings than TwentyFour Select Monthly Income Fund. TwentyFour Select Monthly Income Fund is trading at a lower price-to-earnings ratio than Edinburgh Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TwentyFour Select Monthly Income Fund£17.70M18.10N/A£5.7514.90
Edinburgh Investment£79.43M13.19£180.50M£55.9115.11

Edinburgh Investment has a net margin of 89.72% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. Edinburgh Investment's return on equity of 7.03% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
TwentyFour Select Monthly Income Fund57.51% 5.95% N/A
Edinburgh Investment 89.72%7.03%6.69%

TwentyFour Select Monthly Income Fund has a beta of 0.657, indicating that its share price is 34% less volatile than the broader market. Comparatively, Edinburgh Investment has a beta of 0.965, indicating that its share price is 4% less volatile than the broader market.

15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. Comparatively, 9.7% of Edinburgh Investment shares are owned by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are owned by insiders. Comparatively, 0.3% of Edinburgh Investment shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.2%. Edinburgh Investment pays an annual dividend of GBX 30.20 per share and has a dividend yield of 3.6%. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Edinburgh Investment pays out 54.0% of its earnings in the form of a dividend.

In the previous week, Edinburgh Investment had 5 more articles in the media than TwentyFour Select Monthly Income Fund. MarketBeat recorded 5 mentions for Edinburgh Investment and 0 mentions for TwentyFour Select Monthly Income Fund. Edinburgh Investment's average media sentiment score of 1.25 beat TwentyFour Select Monthly Income Fund's score of 0.00 indicating that Edinburgh Investment is being referred to more favorably in the news media.

Company Overall Sentiment
TwentyFour Select Monthly Income Fund Neutral
Edinburgh Investment Positive

Summary

Edinburgh Investment beats TwentyFour Select Monthly Income Fund on 11 of the 14 factors compared between the two stocks.

Get TwentyFour Select Monthly Income Fund News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMIF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMIF vs. The Competition

MetricTwentyFour Select Monthly Income FundCapital Markets IndustryFinance SectorLON Exchange
Market Cap£320.40M£5.66B£14.09B£2.92B
Dividend Yield8.22%7.42%5.89%6.22%
P/E Ratio14.9031.5826.19366.70
Price / Sales18.101,231.67513.7983,694.82
Price / CashN/A48.0730.8427.89
Price / BookN/A3.582.786.60
Net IncomeN/A£419.48M£1.32B£5.89B
7 Day Performance-0.12%7.80%4.30%12.36%
1 Month Performance-0.58%-0.11%1.14%1.00%
1 Year Performance-1.72%6.73%11.38%21.13%

TwentyFour Select Monthly Income Fund Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMIF
TwentyFour Select Monthly Income Fund
N/AGBX 85.70
+0.4%
N/A-2.1%£320.40M£17.70M14.90N/A
JFJ
JPMorgan Japanese
N/AGBX 818
+0.4%
N/A+24.0%£1.24B£245.55M5.49N/A
GROW
Molten Ventures
1.4515 of 5 stars
GBX 707
+0.4%
GBX 638.67
-9.7%
+91.1%£1.22B£148M10.2520
FCSS
Fidelity China Special
N/AGBX 264
+0.6%
N/A-15.7%£1.19B£146.54M8.87N/A
BPCR
BioPharma Credit
N/AGBX 0.98
-0.2%
N/A+3.2%£1.10B£132.06M0.09N/A

Related Companies and Tools


This page (LON:SMIF) was last updated on 9/8/2026 by MarketBeat.com Staff.
From Our Partners